iSpecimen (ISPC) Cost of Revenue (2020 - 2026)

iSpecimen's Cost of Revenue history runs 7 years deep, the most recent figure standing at $84410.0 for Q1 2026.

• In Q1 2026, Cost of Revenue fell 87.16% year-over-year to $84410.0; the TTM figure through Mar 2026 stood at $1.3 million (down 73.86% YoY), while the FY2025 annual figure was $1.7 million, down 66.48% from the prior year.
• Cost of Revenue for Q1 2026 stood at $84410.0, down from $550950.0 in the prior quarter.
• The five-year high for Cost of Revenue was $1.6 million in Q3 2024, with the low at $84410.0 in Q1 2026.
• The 5-year median for Cost of Revenue is $1.1 million (2023), against an average of $983847.4.
• The sharpest annual moves came in 2024 and 2026: Cost of Revenue soared 66.86% in 2024, then tumbled 87.16% in 2026.
• iSpecimen's Cost of Revenue stood at $1.4 million in 2022, then gained by 1.25% to $1.4 million in 2023, then dropped by 10.57% to $1.3 million in 2024, then slumped by 56.83% to $550950.0 in 2025, then tumbled by 84.68% to $84410.0 in 2026.
• Business Quant data shows ISPC's Cost of Revenue at $84410.0 in Q1 2026, $550950.0 in Q4 2025, and $204593.0 in Q3 2025.